Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants
Clinical trial NCT05995691 · COMPLETED
Trial details
- NCT number
- NCT05995691
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2015-12-04
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.